Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
|
|
VOLITIONRX LTD (VNRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
8-K
| Appointed a new director |
| 06/14/2022 |
8-K
| Quarterly results |
| 06/22/2021 |
8-K
| Quarterly results |
| 06/18/2019 |
8-K
| Quarterly results |
| 06/11/2012 |
8-K/A
| Form 8-K - Current report [amend] |
| 05/08/2012 |
8-K/A
| Resignation/termination of a director, Appointed a new director |
| 04/05/2012 |
8-K/A
| Form 8-K - Current report [amend] |
| 02/24/2012 |
8-K/A
| Form 8-K - Current report [amend] |
| 01/11/2012 |
8-K/A
| Appointed a new director|
Docs:
|
"EXHIBIT 3.1 CERTIFICATE FOR RENEWAL AND REVIVAL OF CHARTER",
"Patent License Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Amended Patent License Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Extension Letter Agreement by and between Cronos Therapeutics Limited and Imperial College Innovations Limited",
"Patent License Agreement by and between ValiRX PLC and Chroma Therapeutics Limited",
"Contract Repayable Grant Advance on the Diagnosis of Colorectal Cancer by “NucleosomicsTM” by and between ValiBio SA and The Walloon Region",
"Non-Exploitation and Third Party Patent License Agreement by and among ValiBio SA, ValiRX PLC and The Walloon Region",
"Agreement by and between Singapore Volition and PB Commodities Pte Limited",
"Share Purchase Agreement by and between Singapore Volition and ValiRX PLC",
"Deed of Novation by and among Singapore Volition Pte Limited, ValiRX PLC, ValiBio SA and Chroma Therapeutics Limited" |
|
|
|